Pyrrolo-pyrazine derivatives useful as CB1-modulators

Details for Australian Patent Application No. 2004292493 (hide)

Owner AstraZeneca AB

Inventors Cheng, Leifeng

Agent Davies Collison Cave

Pub. Number AU-B-2004292493

PCT Pub. Number WO2005/051953

Priority 0327331.5 25.11.03 GB

Filing date 24 November 2004

Wipo publication date 9 June 2005

Acceptance publication date 24 January 2008

International Classifications

A61K 31/415 (2006.01) - 1,2-Diazoles

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

Event Publications

1 June 2006 PCT application entered the National Phase

  PCT publication WO2005/051953 Priority application(s): WO2005/051953

24 January 2008 Application Accepted

  Published as AU-B-2004292493

22 May 2008 Standard Patent Sealed

17 June 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004292494-Twin master cylinder assembly

2004292452-Free flowing dry back-up insulating material